Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TPSB1 Inhibitors

The chemical class of "TPSB1 Inhibitors" represents a group of compounds that, although not directly targeting TPSB1, have the potential to influence its activity or expression indirectly. These inhibitors primarily focus on modulating serine protease activity or influencing pathways that interact with or regulate TPSB1.

Serine protease inhibitors like Gabexate Mesilate, Nafamostat, and Camostat Mesilate can potentially alter TPSB1 activity by inhibiting protease function. Their mode of action might provide an indirect approach to modulating TPSB1, given its role as a serine protease. Sivelestat, while primarily targeting neutrophil elastase, could affect inflammatory responses wherein TPSB1 is involved.

Aprotinin, a broad-spectrum serine protease inhibitor, and Tranexamic Acid, which inhibits plasminogen activation, could also indirectly modulate proteolytic pathways related to TPSB1. Ecallantide and Conestat Alfa, inhibitors of kallikrein and C1 respectively, might influence protease pathways and thus have an indirect impact on TPSB1 activity.

Marimastat, a matrix metalloproteinase inhibitor, and Omiganan, an antimicrobial peptide, may affect cellular processes and signaling pathways that intersect with the functional pathways of TPSB1. Doxycycline, known for its antibiotic and metalloproteinase inhibitory activities, might indirectly affect TPSB1 through its influence on matrix remodeling and inflammatory processes.

Ketotifen, as a mast cell stabilizer, represents an indirect approach to modulating TPSB1, given the predominant expression of TPSB1 in mast cells. By stabilizing mast cells, Ketotifen could potentially influence the release and activity of TPSB1.

This class of inhibitors and activators is characterized by its indirect mode of action, targeting various aspects of protease activity, cellular signaling, and inflammation to potentially influence the activity or expression of TPSB1. Each compound has distinct pharmacological properties and modes of action, reflecting the complexity of protease regulation and the multifaceted nature of enzyme activity within cellular systems. The diversity in this chemical class underscores the broad spectrum of molecular interactions and pathways that can be modulated to affect specific proteins, such as TPSB1, in complex biological environments.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Gabexate mesylate

56974-61-9sc-215066
5 mg
$100.00
(0)

Serine protease inhibitor, could potentially alter TPSB1 activity by inhibiting protease function.

Nafamostat mesylate

82956-11-4sc-201307
sc-201307A
10 mg
50 mg
$82.00
$306.00
4
(1)

Another serine protease inhibitor, might modulate TPSB1 by targeting proteolytic activity.

Sivelestat

127373-66-4sc-203938
1 mg
$105.00
2
(1)

Inhibitor of neutrophil elastase, could indirectly affect TPSB1-related pathways in inflammatory responses.

Camostat mesylate

59721-29-8sc-203867
sc-203867A
sc-203867B
sc-203867C
sc-203867D
sc-203867E
10 mg
50 mg
500 mg
1 g
10 g
100 g
$43.00
$183.00
$312.00
$624.00
$2081.00
$4474.00
5
(0)

Serine protease inhibitor, may influence TPSB1 activity by altering protease pathways.

Aprotinin

9087-70-1sc-3595
sc-3595A
sc-3595B
10 mg
100 mg
1 g
$112.00
$408.00
$3000.00
51
(2)

Broad-spectrum serine protease inhibitor, potentially modulating TPSB1 activity.

Tranexamic acid

1197-18-8sc-204921
sc-204921A
5 g
10 g
$29.00
$50.00
10
(1)

Inhibits plasminogen activation, could indirectly affect proteolytic pathways involving TPSB1.

Marimastat

154039-60-8sc-202223
sc-202223A
sc-202223B
sc-202223C
sc-202223E
5 mg
10 mg
25 mg
50 mg
400 mg
$168.00
$218.00
$404.00
$629.00
$4900.00
19
(1)

Matrix metalloproteinase inhibitor, might affect pathways indirectly related to TPSB1.

Doxycycline-d6

564-25-0 unlabeledsc-218274
1 mg
$16500.00
(0)

Antibiotic with metalloproteinase inhibitory activity, might indirectly affect TPSB1.